Saxenda

Active Ingredient(s): Liraglutide Recombinant
FDA Approved: * December 23, 2014
Pharm Company: * NOVO NORDISK INC
Category: Diabetes

Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management.[5][6] In diabetes it is a less preferred agent compared to metformin.[5][7] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.[5][8] It is given by injection under the skin.[5] Com... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Saxenda 6 mg/ml Subcutaneous Injection, Solution
NDC: 50090-4257
Labeler:
A-s Medication Solutions

Related Brands

Drugs with the same active ingredients